18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer
Version:
2
ID:
7-20 Version 2
Oct 2012
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Patient Population
Adult patients with lung cancer.
Research Question(s)
What is the role of 18-Fluorodeoxyglucose (18FDG) Positron Emission Tomography (PET) in:
- The diagnosis of solitary pulmonary nodules (SPN)?
- The staging of primary non-small cell lung cancer (NSCLC) at initial diagnosis?
- The staging of primary small cell lung cancer (SCLC)? Outcomes of interest include accuracy measures of imaging and the impact of PET on patient management and patient outcomes.
![application/pdf pdf download](/sites/ccocancercare/themes/CCOp2/images/icons/application-pdf.png)
![application/pdf pdf download](/sites/ccocancercare/themes/CCOp2/images/icons/application-pdf.png)